 | • レポートコード：GIR201111775 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ヘプシジンの世界市場を調査対象にし、ヘプシジンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（DS-79182026、M-009、PRS-080、PTG-300、その他）、用途別分析（急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Daiichi Sankyo Co Ltd、Noxxon Pharma AG、Pieris Pharmaceuticals Inc、Protagonist Therapeutics Inc ・メーカー別販売量、売上、市場シェア ・ヘプシジンの地域別市場分析 ・ヘプシジンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ヘプシジンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ヘプシジンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ヘプシジンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ヘプシジンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ヘプシジンの種類別市場規模2015-2020：DS-79182026、M-009、PRS-080、PTG-300、その他 ・ヘプシジンの用途別市場規模2015-2020：急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他 ・ヘプシジンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Hepcidin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Hepcidin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hepcidin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hepcidin market has been segmented into
DS-79182026
M-009
PRS-080
PTG-300
Others
By Application, Hepcidin has been segmented into:
Acute Inflammation
Anemia
Iron Deficiency Anemia
Sickle Cell Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hepcidin market presented in the report. This section sheds light on the sales growth of different regional and country-level Hepcidin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hepcidin market.
The report offers in-depth assessment of the growth and other aspects of the Hepcidin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Hepcidin Market Share Analysis
Hepcidin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hepcidin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hepcidin sales, revenue and market share for each player covered in this report.
The major players covered in Hepcidin are:
Daiichi Sankyo Co Ltd
Noxxon Pharma AG
Pieris Pharmaceuticals Inc
Protagonist Therapeutics Inc
Among other players domestic and global, Hepcidin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepcidin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepcidin, with price, sales, revenue and global market share of Hepcidin in 2018 and 2019.
Chapter 3, the Hepcidin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepcidin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Hepcidin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Hepcidin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Hepcidin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepcidin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 DS-79182026
1.2.3 M-009
1.2.4 PRS-080
1.2.5 PTG-300
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepcidin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Acute Inflammation
1.3.3 Anemia
1.3.4 Iron Deficiency Anemia
1.3.5 Sickle Cell Disease
1.3.6 Others
1.4 Overview of Global Hepcidin Market
1.4.1 Global Hepcidin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Daiichi Sankyo Co Ltd
2.1.1 Daiichi Sankyo Co Ltd Details
2.1.2 Daiichi Sankyo Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Daiichi Sankyo Co Ltd SWOT Analysis
2.1.4 Daiichi Sankyo Co Ltd Product and Services
2.1.5 Daiichi Sankyo Co Ltd Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Noxxon Pharma AG
2.2.1 Noxxon Pharma AG Details
2.2.2 Noxxon Pharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Noxxon Pharma AG SWOT Analysis
2.2.4 Noxxon Pharma AG Product and Services
2.2.5 Noxxon Pharma AG Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pieris Pharmaceuticals Inc
2.3.1 Pieris Pharmaceuticals Inc Details
2.3.2 Pieris Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pieris Pharmaceuticals Inc SWOT Analysis
2.3.4 Pieris Pharmaceuticals Inc Product and Services
2.3.5 Pieris Pharmaceuticals Inc Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Protagonist Therapeutics Inc
2.4.1 Protagonist Therapeutics Inc Details
2.4.2 Protagonist Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Protagonist Therapeutics Inc SWOT Analysis
2.4.4 Protagonist Therapeutics Inc Product and Services
2.4.5 Protagonist Therapeutics Inc Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Hepcidin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Hepcidin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Hepcidin Manufacturer Market Share in 2019
3.3.2 Top 6 Hepcidin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Hepcidin Sales, Revenue and Market Share by Regions
4.1.1 Global Hepcidin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hepcidin Revenue and Market Share by Regions (2015-2020)
4.2 North America Hepcidin Sales and Growth Rate (2015-2020)
4.3 Europe Hepcidin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Hepcidin Sales and Growth Rate (2015-2020)
4.5 South America Hepcidin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Hepcidin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Hepcidin Sales, Revenue and Market Share by Country
5.1.1 North America Hepcidin Sales and Market Share by Country (2015-2020)
5.1.2 North America Hepcidin Revenue and Market Share by Country (2015-2020)
5.2 United States Hepcidin Sales and Growth Rate (2015-2020)
5.3 Canada Hepcidin Sales and Growth Rate (2015-2020)
5.4 Mexico Hepcidin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Hepcidin Sales, Revenue and Market Share by Country
6.1.1 Europe Hepcidin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Hepcidin Revenue and Market Share by Country (2015-2020)
6.2 Germany Hepcidin Sales and Growth Rate (2015-2020)
6.3 UK Hepcidin Sales and Growth Rate (2015-2020)
6.4 France Hepcidin Sales and Growth Rate (2015-2020)
6.5 Russia Hepcidin Sales and Growth Rate (2015-2020)
6.6 Italy Hepcidin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Hepcidin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Hepcidin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Hepcidin Revenue and Market Share by Regions (2015-2020)
7.2 China Hepcidin Sales and Growth Rate (2015-2020)
7.3 Japan Hepcidin Sales and Growth Rate (2015-2020)
7.4 Korea Hepcidin Sales and Growth Rate (2015-2020)
7.5 India Hepcidin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Hepcidin Sales and Growth Rate (2015-2020)
7.7 Australia Hepcidin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Hepcidin Sales, Revenue and Market Share by Country
8.1.1 South America Hepcidin Sales and Market Share by Country (2015-2020)
8.1.2 South America Hepcidin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Hepcidin Sales and Growth Rate (2015-2020)
8.3 Argentina Hepcidin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Hepcidin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Hepcidin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Hepcidin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Hepcidin Sales and Growth Rate (2015-2020)
9.3 Turkey Hepcidin Sales and Growth Rate (2015-2020)
9.4 Egypt Hepcidin Sales and Growth Rate (2015-2020)
9.5 South Africa Hepcidin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Hepcidin Sales and Market Share by Type (2015-2020)
10.2 Global Hepcidin Revenue and Market Share by Type (2015-2020)
10.3 Global Hepcidin Price by Type (2015-2020)
11 Global Hepcidin Market Segment by Application
11.1 Global Hepcidin Sales Market Share by Application (2015-2020)
11.2 Global Hepcidin Revenue Market Share by Application (2015-2020)
11.3 Global Hepcidin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Hepcidin Sales, Revenue and Growth Rate (2021-2025)
12.2 Hepcidin Market Forecast by Regions (2021-2025)
12.2.1 North America Hepcidin Market Forecast (2021-2025)
12.2.2 Europe Hepcidin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Hepcidin Market Forecast (2021-2025)
12.2.4 South America Hepcidin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Hepcidin Market Forecast (2021-2025)
12.3 Hepcidin Market Forecast by Type (2021-2025)
12.3.1 Global Hepcidin Sales Forecast by Type (2021-2025)
12.3.2 Global Hepcidin Market Share Forecast by Type (2021-2025)
12.4 Hepcidin Market Forecast by Application (2021-2025)
12.4.1 Global Hepcidin Sales Forecast by Application (2021-2025)
12.4.2 Global Hepcidin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Hepcidin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hepcidin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hepcidin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Co Ltd Hepcidin Major Business
Table 9. Daiichi Sankyo Co Ltd Hepcidin Total Revenue (USD Million) (2018-2019)
Table 10. Daiichi Sankyo Co Ltd SWOT Analysis
Table 11. Daiichi Sankyo Co Ltd Hepcidin Product and Services
Table 12. Daiichi Sankyo Co Ltd Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Noxxon Pharma AG Basic Information, Manufacturing Base and Competitors
Table 14. Noxxon Pharma AG Hepcidin Major Business
Table 15. Noxxon Pharma AG Hepcidin Total Revenue (USD Million) (2018-2019)
Table 16. Noxxon Pharma AG SWOT Analysis
Table 17. Noxxon Pharma AG Hepcidin Product and Services
Table 18. Noxxon Pharma AG Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pieris Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Pieris Pharmaceuticals Inc Hepcidin Major Business
Table 21. Pieris Pharmaceuticals Inc Hepcidin Total Revenue (USD Million) (2018-2019)
Table 22. Pieris Pharmaceuticals Inc SWOT Analysis
Table 23. Pieris Pharmaceuticals Inc Hepcidin Product and Services
Table 24. Pieris Pharmaceuticals Inc Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Protagonist Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 26. Protagonist Therapeutics Inc Hepcidin Major Business
Table 27. Protagonist Therapeutics Inc Hepcidin Total Revenue (USD Million) (2018-2019)
Table 28. Protagonist Therapeutics Inc SWOT Analysis
Table 29. Protagonist Therapeutics Inc Hepcidin Product and Services
Table 30. Protagonist Therapeutics Inc Hepcidin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Hepcidin Sales by Manufacturer (2018-2019) (K Pcs)
Table 32. Global Hepcidin Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Hepcidin Sales by Regions (2015-2020) (K Pcs)
Table 34. Global Hepcidin Sales Market Share by Regions (2015-2020)
Table 35. Global Hepcidin Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Hepcidin Sales by Countries (2015-2020) (K Pcs)
Table 37. North America Hepcidin Sales Market Share by Countries (2015-2020)
Table 38. North America Hepcidin Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Hepcidin Revenue Market Share by Countries (2015-2020)
Table 40. Europe Hepcidin Sales by Countries (2015-2020) (K Pcs)
Table 41. Europe Hepcidin Sales Market Share by Countries (2015-2020)
Table 42. Europe Hepcidin Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Hepcidin Sales by Regions (2015-2020) (K Pcs)
Table 44. Asia-Pacific Hepcidin Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Hepcidin Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Hepcidin Sales by Countries (2015-2020) (K Pcs)
Table 47. South America Hepcidin Sales Market Share by Countries (2015-2020)
Table 48. South America Hepcidin Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Hepcidin Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Hepcidin Sales by Countries (2015-2020) (K Pcs)
Table 51. Middle East & Africa Hepcidin Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Hepcidin Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Hepcidin Revenue Market Share by Countries (2015-2020)
Table 54. Global Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 55. Global Hepcidin Sales Share by Type (2015-2020)
Table 56. Global Hepcidin Revenue by Type (2015-2020) (USD Million)
Table 57. Global Hepcidin Revenue Share by Type (2015-2020)
Table 58. Global Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 59. Global Hepcidin Sales Share by Application (2015-2020)
Table 60. Global Hepcidin Sales Forecast by Regions (2021-2025) (K Pcs)
Table 61. Global Hepcidin Market Share Forecast by Regions (2021-2025)
Table 62. Global Hepcidin Sales Forecast by Type (2021-2025) (K Pcs)
Table 63. Global Hepcidin Market Share Forecast by Type (2021-2025)
Table 64. Global Hepcidin Sales Forecast by Application (2021-2025)
Table 65. Global Hepcidin Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Hepcidin Picture
Figure 2. Global Sales Market Share of Hepcidin by Type in 2019
Figure 3. DS-79182026 Picture
Figure 4. M-009 Picture
Figure 5. PRS-080 Picture
Figure 6. PTG-300 Picture
Figure 7. Others Picture
Figure 8. Hepcidin Sales Market Share by Application in 2018
Figure 9. Acute Inflammation Picture
Figure 10. Anemia Picture
Figure 11. Iron Deficiency Anemia Picture
Figure 12. Sickle Cell Disease Picture
Figure 13. Others Picture
Figure 14. Global Hepcidin Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Hepcidin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Hepcidin Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Hepcidin Sales Market Share by Manufacturer in 2019
Figure 35. Global Hepcidin Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Hepcidin Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Hepcidin Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Hepcidin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Hepcidin Revenue Market Share by Regions (2015-2020)
Figure 42. Global Hepcidin Revenue Market Share by Regions in 2018
Figure 43. North America Hepcidin Sales and Growth Rate (2015-2020)
Figure 44. Europe Hepcidin Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Hepcidin Sales and Growth Rate (2015-2020)
Figure 46. South America Hepcidin Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Hepcidin Sales and Growth Rate (2015-2020)
Figure 48. North America Hepcidin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Hepcidin Sales Market Share by Countries (2015-2020)
Figure 50. North America Hepcidin Sales Market Share by Countries in 2018
Figure 51. North America Hepcidin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Hepcidin Revenue Market Share by Countries in 2018
Figure 53. United States Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Hepcidin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Hepcidin Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Hepcidin Revenue Market Share by Countries in 2019
Figure 59. Germany Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Hepcidin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Hepcidin Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Hepcidin Revenue Market Share by Regions 2019
Figure 67. China Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Hepcidin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Hepcidin Sales Market Share by Countries in 2019
Figure 74. South America Hepcidin Revenue Market Share by Countries in 2019
Figure 75. Brazil Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Hepcidin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Hepcidin Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Hepcidin Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Hepcidin Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Hepcidin Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Hepcidin Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Hepcidin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Hepcidin Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Hepcidin Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Hepcidin Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Hepcidin Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Hepcidin Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
鎌状赤血球症関連血管閉塞症の世界市場 2020年 Market Overview The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mil…- 変性椎間板ヘルニアの世界市場 2020年 Market Overview The global Degenerative Disc Disease Threpeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Degener…
- ヘモグロビン症治療薬の世界市場 2020年 Market Overview The global Hemoglobinopathies Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hemoglobinopathies D…
- 救急医療用無針コネクタの世界市場 2020年 Market Overview The Acute Care Needleless Connector market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 急性呼吸窮迫症候群治療の世界市場 2020年 Market Overview The global Acute Respiratory Distress Syndrome Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …